Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety Read more
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs Read more
CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaques Read more
February 5, 2025 @ 8:30 am

The agenda at BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed.